Nycomed Pharma AS
NorwayFDA applicant, unverified
- Devices
- 1
What Nycomed Pharma AS makes
Nycomed Pharma AS manufactures NYCOPLASTIN, a surgical hemostatic agent designed to control bleeding during procedures by promoting blood clotting at the application site.
NYCOPLASTIN is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Nycoplastin Ref K920767
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nycomed Pharma AS have in the registry?
The registry currently lists 1 device for Nycomed Pharma AS. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nycomed Pharma AS's devices?
Among its 1 most recently registered device, Nycomed Pharma AS has devices listed in FDA 510(k) (1 device).
What risk classes do Nycomed Pharma AS's devices fall under?
Among its 1 most recently registered device, the classes recorded for Nycomed Pharma AS's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Nycomed Pharma AS in the registry?
The most recently registered devices listed for Nycomed Pharma AS include NYCOPLASTIN.